[1]邹永东,梁泽秋,董瑶,等.促进Aβ42形成不溶性聚集物的一种真菌化合物[J].深圳大学学报理工版,2016,33(1):25-32.[doi:10.3724/SP.J.1249.2016.01025]
 Zou Yongdong,Liang Zeqiu,et al.Promoting action of demethoxyviridin on Aβ42 oligomers to form insoluble macromolecule aggregates[J].Journal of Shenzhen University Science and Engineering,2016,33(1):25-32.[doi:10.3724/SP.J.1249.2016.01025]
点击复制

促进Aβ42形成不溶性聚集物的一种真菌化合物()
分享到:

《深圳大学学报理工版》[ISSN:1000-2618/CN:44-1401/N]

卷:
第33卷
期数:
2016年第1期
页码:
25-32
栏目:
生物工程
出版日期:
2016-01-20

文章信息/Info

Title:
Promoting action of demethoxyviridin on Aβ42 oligomers to form insoluble macromolecule aggregates
文章编号:
201601004
作者:
邹永东12梁泽秋12董瑶13陈国栋4刘国宝12郑易之12
1)深圳大学生命与海洋科学学院,广东深圳 518060;2)深圳市微生物基因工程重点实验室,广东深圳 518060
3)深圳市海洋生物资源与生态环境重点实验室,广东深圳 518060
4)暨南大学药学院,中药及天然药物研究所,广东广州510632
Author(s):
Zou Yongdong1 2 Liang Zeqiu1 2 Dong Yao1 3 Chen Guodong4 Liu Guobao1 2 and Zheng Yizhi12
1) College of Life and Marine Science, Shenzhen University, Shenzhen 518060, Guangdong Province, P.R.China
2) Shenzhen Key Laboratory of Microbial Genetic Engineering, Shenzhen 518060, Guangdong Province, P.R.China
3) Shenzhen Key Laboratory of Marine Bioresources and Ecology, Shenzhen 518060, Guangdong Province, P.R.China
4) College of Pharmacy, Institute of Traditional Chinese Medicine and Natural Products, Jinan University, Guangzhou 510632, Guangdong Province, P.R.China
关键词:
微生物药物学阿尔茨海默症β-类淀粉蛋白Aβ42寡聚体Aβ42聚集Aβ42大分子聚集沉淀真菌化合物
Keywords:
microbial pharmacology Alzheimer disease amyloid-β (Aβ) Aβ42 oligomer Aβ42 aggregation Aβ42 macromolecular aggregate precipitate fungal compound
分类号:
R 93
DOI:
10.3724/SP.J.1249.2016.01025
文献标志码:
A
摘要:
β-类淀粉蛋白42 (amyloid-β42, Aβ42)聚集形成的可溶性寡聚体具有神经细胞毒性,是引起阿尔茨海默症的主要原因之一.通过浊度法、聚丙烯酰胺凝胶电泳(sodium dodecyl sulfate-polyacrylamide gelelectrophoresis,SDS-PAGE)和原子力显微镜(atomic force microscopy, AFM)技术,分析在真菌化合物demethoxyviridin存在情况下,Aβ42聚集过程中荧光强度、浊度、寡聚体和聚集物的比例及颗粒表观形态等动态变化之间的对应关系.结果表明,化合物demethoxyviridin可明显促进Aβ42小分子寡聚体形成高分子量寡聚体后,形成不溶性大分子聚集物沉淀,减少可溶性Aβ42寡聚体比例.探讨了硫磺素T荧光法、浊度法、SDS-PAGE法和AFM法在研究Aβ42聚集及活性化合物影响Aβ42聚集中的互补性,认为综合应用4种方法有助于揭示活性化合物影响Aβ42寡聚体沉淀形成的分子机理.
Abstract:
Amyloid beta (Aβ) is crucially involved in Alzheimer’s disease, and soluble Aβ42 oligomers are the main neurotoxic species. In this paper, the experimental methods, including standard thioflavin T (ThT) fluorescence assay, turbimetric method, sodium dodecyl sulfate-polyacrylamide gelelectrophoresis (SDS-PAGE) and atomic force microscopy (AFM), are applied to investigate the relationship among the thioflavin T fluorescence, the turbidity, the proportion and the surface shape of Aβ42 oligomers and aggregates during the Aβ42 aggregation procedure. The results show that the fungal compound demethoxyviridin could clearly promote soluble small molecular Aβ42 oligomers to form insoluble macromolecular aggregate precipitates via high molecular weight oligomers. In addition, the complementarities of the ThT fluorescence assay, turbimetric method, SDS-PAGE and AFM on Aβ42 aggregation procedure are discussed. The comprehensive application of these methods is helpful to reveal the molecular mechanism of the effect of the active compounds on the formation of Aβ42 oligomers and their precipitation.

参考文献/References:

[1] 倪嘉缵, 陈平, 刘琼, 等. 阿尔茨海默病的防治策略研究进展[J]. 深圳大学学报理工版, 2013, 30(4): 331-348.
Ni Jiazuan, Chen Ping, Liu Qiong, et al. Advance reseach on strategies for the prevention of Alzheimer’s disease[J]. Journal of Shenzhen University Science and Engineering, 2013, 30(4): 331-348.(in Chinese)
[2] 李冰石, 薛山, 宋国丽. 纳米粒子对amyloid-β聚集的影响的研究进展[J]. 深圳大学学报理工版, 2015, 32(6): 601-609.
Li Bingshi, Xue Shan, Song Guoli. Review of the influence of nanoparticles on aggregation of amyloid-β[J]. Journal of Shenzhen University Science and Engineering, 2015, 32(6): 601-609.(in Chinese)
[3] Wu Haiqiang, Zhang Fang, Williamson N, et al. Effects of secondary metabolite extract from Phomopsisocculta on beta-amyloid aggregation[J]. PLOS One, 2014, 9(10): e109438.
[4] Citron M. Alzheimer’s disease: strategies for disease modification[J]. Nature Reviews Drug Discovery, 2010, 9(5): 387-398.
[5] Fu Ziao, Aucoin D, Ahmed M, et al. Capping of Aβ42 oligomers by small molecule inhibitors[J]. Biochemistry, 2014, 53(50): 7893-7903.
[6] Stefani M. Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer’s disease and other diseases with amyloid deposits[J]. Progress in Neurobiology, 2012, 99(3): 226-245.
[7] Ehrnhoefer D E, Bieschke J, Boeddrich A, et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers[J]. Nature Structural & Molecular Biology, 2008, 15(6): 558-566.
[8] Mastrangelo I A, Ahmed M, Sato T, et al. High-resolution atomic force microscopy of soluble Aβ42 oligomers[J]. Journal of Molecular Biology, 2006, 358(1): 106-119.
[9] Kayed R, Head E, Thompson J L, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis[J]. Science, 2003, 300(5618): 486-489.
[10] Kelly B L, Ferreira A. Beta-amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons[J]. Journal of Biological Chemistry, 2006, 281(38): 28079-28089.
[11] Caesar I, Jonson M, Nilsson K P R, et al. Curcumin promotes A-beta fibrillation and reduces neurotoxicity in transgenic Drosophila [J]. PLOS One, 2012, 7(2): e31424.
[12] Cui Lili, Zhang Yuan, Cao Hao, et al. Ferulic acid inhibits the transition of amyloid-beta 42 monomers to oligomers but accelerates the transition from oligomers to fibrils[J]. Journal of Alzheimer’s Disease, 2013, 37(1): 19-28.
[13] Ladiwala A R A, Lin J C, Bale S S, et al. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers[J]. Journal of Biological Chemistry, 2010, 285(31): 24228-24237.
[14] Zheng Qichang, Chen Guodong, Kong Mingzhu, et al. Nodulisporisteriods A and B, the first 3,4-seco-4-methyl-progesteroids from Nodulisporium sp.[J]. Steroids, 2013, 78(9): 896-901.
[15] Keskitalo S, Farkas M, Hanenberg M, et al. Reciprocal modulation of Aβ42 aggregation by copper and homocysteine[J]. Frontiers in Aging Neuroscience, 2014, 6: 237.
[16] Bhattacharya A, Prajapati R, Chatterjee S, et al. Concentration-dependent reversible self-oligomerization of serum albumins through intermolecular β-sheet formation[J]. Langmuir, 2014, 30(49): 14894-14904.
[17] Han Sunho, Chang Yujin, Jung Eunsun, et al. Effective screen for amyloid beta aggregation inhibitor using amyloid beta-conjugated gold nanoparticles[J]. Journal of Nanomedicine, 2011, 6: 1-12.
[18] Fowler S B, Poon S, Muff R, et al. Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin[J]. Proceedings of the National Academy of Sciences, 2005, 102(29): 10105-10110.
[19] Takai E, Uda K, Yoshida T, et al. Cysteine inhibits the fibrillisation and cytotoxicity of amyloid-beta 40 and 42: implications for the contribution of the thiophilic interaction[J]. Physical Chemistry Chemical Physics, 2014, 16(8): 3566-3572.
[20] Poduslo J F, Howell K G, Olson N C, et al. Alzheimer’s disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillaraggregates and late stage fibrils[J]. Biochemistry, 2012, 51(19): 3993-4003.
[21] Poduslo J F, Howell K G. Unique molecular signatures of Alzheimer’s disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation[J]. Journal of Neuroscience Research, 2015, 93(3): 410-423.
[22] Jan A, Hartley D M, Lashuel H A. Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer’s disease research[J]. Nature Protocols, 2010, 5(6): 1186-1209.
[23] Necula M, Kayed R, Milton S, et al. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillizationpathways are independent and distinct[J]. Journal of Biological Chemistry, 2007, 282(14): 10311-10324.

相似文献/References:

[1]李冰石,薛山,宋国丽.纳米粒子对amyloid-β聚集的影响的研究进展[J].深圳大学学报理工版,2015,32(6):601.[doi:10.3724/SP.J.1249.2015.06601]
 Li Bingshi,Xue Shan,and Song Guoli.Review of the influence of nanoparticles on aggregation of amyloid-β[J].Journal of Shenzhen University Science and Engineering,2015,32(1):601.[doi:10.3724/SP.J.1249.2015.06601]

备注/Memo

备注/Memo:
Received:2015-09-22;Accepted:2015-12-07
Foundation:National Natural Science Foundation of China (81202441)
 Corresponding author:Professor Zheng Yizhi. E-mail: yzzheng@szu.edu.cn
Citation:Zou Yongdong, Liang Zeqiu, Dong Yao, et al. Promoting action of demethoxyviridin on Aβ42 oligomers to form insoluble macromolecule aggregates[J]. Journal of Shenzhen University Science and Engineering, 2016, 33(1): 25-32.(in Chinese)
基金项目:国家自然科学基金资助项目(81202441)
作者简介:邹永东(1968—),男,深圳大学高级实验师.研究方向:植物生物技术及天然产物应用. E-mail:zouyd@szu.edu.cn
引文:邹永东,梁泽秋,董瑶,等. 促进Aβ42形成不溶性聚集物的一种真菌化合物[J]. 深圳大学学报理工版,2016,33(1):25-32.
更新日期/Last Update: 2016-01-14